[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.141.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
December 10, 2003

Inflammation, Hypertension, and the Metabolic Syndrome

Author Affiliations

Author Affiliations: Departments of Clinical Nutrition, Internal Medicine, and the Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas.

JAMA. 2003;290(22):3000-3002. doi:10.1001/jama.290.22.3000

In this issue of THE JOURNAL, Sesso and colleagues1 report a positive relationship between increased serum levels of C-reactive protein and the risk for development of incident hypertension in participants of the Women's Health Study. A total of 20 525 women were followed up prospectively for a median of 7.8 years, during which time approximately one fourth of the women acquired elevated blood pressure; those with higher levels of C-reactive protein were more likely to develop hypertension. C-reactive protein levels in the upper ranges of the normal distribution (high-normal levels of C-reactive protein) are widely believed to reflect a state of low-grade chronic inflammation; therefore, the association between higher C-reactive protein levels and new-onset hypertension led Sesso et al1 to suggest that hypertension may be an inflammatory disease.

First Page Preview View Large
First page PDF preview
First page PDF preview
×